These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 25014609)

  • 1. Betahistine metabolites, aminoethylpyridine, and hydroxyethylpyridine increase cochlear blood flow in guinea pigs in vivo.
    Bertlich M; Ihler F; Sharaf K; Weiss BG; Strupp M; Canis M
    Int J Audiol; 2014 Oct; 53(10):753-9. PubMed ID: 25014609
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Histaminergic H3-Heteroreceptors as a Potential Mediator of Betahistine-Induced Increase in Cochlear Blood Flow.
    Bertlich M; Ihler F; Freytag S; Weiss BG; Strupp M; Canis M
    Audiol Neurootol; 2015; 20(5):283-93. PubMed ID: 26139562
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low Dose Betahistine in Combination With Selegiline Increases Cochlear Blood Flow in Guinea Pigs.
    Kloos B; Bertlich M; Spiegel JL; Freytag S; Lauer SK; Canis M; Weiss BG; Ihler F
    Ann Otol Rhinol Laryngol; 2023 May; 132(5):519-526. PubMed ID: 35656811
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Betahistine exerts a dose-dependent effect on cochlear stria vascularis blood flow in guinea pigs in vivo.
    Ihler F; Bertlich M; Sharaf K; Strieth S; Strupp M; Canis M
    PLoS One; 2012; 7(6):e39086. PubMed ID: 22745706
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of betahistine metabolites on frog ampullar receptors.
    Botta L; Mira E; Valli S; Zucca G; Perin P; Benvenuti C; Fossati A; Valli P
    Acta Otolaryngol; 2000 Jan; 120(1):25-7. PubMed ID: 10779181
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of capillary pericytes and precapillary arterioles in the vascular mechanism of betahistine in a guinea pig inner ear model.
    Bertlich M; Ihler F; Weiss BG; Freytag S; Strupp M; Jakob M; Canis M
    Life Sci; 2017 Oct; 187():17-21. PubMed ID: 28818391
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Betahistine effects on cochlear blood flow: from the laboratory to the clinic.
    Laurikainen E; Miller JF; Pyykkö I
    Acta Otolaryngol Suppl; 2000; 544():5-7. PubMed ID: 10904793
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of betahistine and of its metabolites on vestibular sensory organs.
    Botta L; Mira E; Valli S; Zucca G; Benvenuti C; Fossati A; Soto E; Guth P; Valli P
    Acta Otorhinolaryngol Ital; 2001 Jun; 21(3 Suppl 66):24-30. PubMed ID: 11677836
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Betahistine or Cinnarizine for treatment of Meniere's disease.
    Djelilovic-Vranic J; Alajbegovic A; Tiric-Campara M; Volic A; Sarajlic Z; Osmanagic E; Todorovic L; Beslagic O
    Med Arch; 2012; 66(6):396-8. PubMed ID: 23409520
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of glycerol on cochlea microcirculation.
    Prazma J
    Acta Otolaryngol; 1981; 92(5-6):459-61. PubMed ID: 7315264
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Report from a Consensus Conference on the treatment of Ménière's disease with betahistine: rationale, methodology and results.
    Casani AP; Guidetti G; Schoenhuber R;
    Acta Otorhinolaryngol Ital; 2018 Oct; 38(5):460-467. PubMed ID: 30498275
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fixed combination of cinnarizine and dimenhydrinate versus betahistine dimesylate in the treatment of Ménière's disease: a randomized, double-blind, parallel group clinical study.
    Novotný M; Kostrica R
    Int Tinnitus J; 2002; 8(2):115-23. PubMed ID: 14763223
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hearing function after betahistine therapy in patients with Ménière's disease.
    Seyed Tootoonchi SJ; Ghiasi S; Shadara P; Samani SM; Fouladi DF
    Braz J Otorhinolaryngol; 2016; 82(5):500-6. PubMed ID: 26810620
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The use of betaserk in patients with cochlear-vestibular disorders].
    Kadymov MI; Poliakova TS; Vladimirova TN
    Vestn Otorinolaringol; 1998; (5):49-50. PubMed ID: 9793432
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Betahistine: what's new on the agenda?
    Barak N
    Expert Opin Investig Drugs; 2008 May; 17(5):795-804. PubMed ID: 18447604
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Using betahistine in the treatment of patients with Menière's disease: a meta-analysis with the current randomized-controlled evidence.
    Devantier L; Hougaard D; Händel MN; Liviu-Adelin Guldfred F; Schmidt JH; Djurhuus B; Callesen HE
    Acta Otolaryngol; 2020 Oct; 140(10):845-853. PubMed ID: 32580600
    [No Abstract]   [Full Text] [Related]  

  • 17. The benefits of betahistine or vestibular rehabilitation (Tetrax biofeedback) on the quality of life and fall risk in patients with Ménière's disease.
    Liu JL; Liu JG; Chen XB; Liu YH
    J Laryngol Otol; 2020 Dec; 134(12):1073-1076. PubMed ID: 33280619
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of blood flow promoting drugs on cochlear blood flow, perilymphatic pO(2) and auditory function in the normal and noise-damaged hypoxic and ischemic guinea pig inner ear.
    Lamm K; Arnold W
    Hear Res; 2000 Mar; 141(1-2):199-219. PubMed ID: 10713508
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Betahistine increases vestibular blood flow.
    Dziadziola JK; Laurikainen EL; Rachel JD; Quirk WS
    Otolaryngol Head Neck Surg; 1999 Mar; 120(3):400-5. PubMed ID: 10064646
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fingolimod (FTY-720) is Capable of Reversing Tumor Necrosis Factor Induced Decreases in Cochlear Blood Flow.
    Bertlich M; Ihler F; Weiss BG; Freytag S; Jakob M; Strupp M; Pellkofer H; Canis M
    Otol Neurotol; 2017 Sep; 38(8):1213-1216. PubMed ID: 28742634
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.